Showing results (911-920 of 1,124) with videos related to

Sort By:
Pageof 113
Hellenic Journal of Nuclear Medicine|April 23, 2010
Incidental finding of bilateral papillary thyroid carcinoma in a patient with primary hyperparathyroidismMehr Sadat Alavi, Negar Azarpira, Mehra Mojallal
Hellenic Journal of Nuclear Medicine|December 17, 2008
Differentiation between malignant transformation and tumour recurrence by (68)Ga-bombesin and (18)F-FDG-PET, in patients with low grade gliomasMarcel Seiz, Antonia Dimitrakopoulou-Strauss, Gerrit A Schubert, et al.
Hellenic Journal of Nuclear Medicine|December 17, 2008
(18)F-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan?Andrei Iagaru, Yingbing Wang, Carina Mari, et al.
Hellenic Journal of Nuclear Medicine|March 31, 2009
Etofibrate enhances 123I-LDL-binding in human liverBarbara Palumbo, Anthony Oguogho, Renato Palumbo, et al.
Hellenic Journal of Nuclear Medicine|March 31, 2009
Evaluation by 18F-FDG-PET of patients with anal squamous cell carcinomaAndrei Iagaru, Rabi Kundu, Hossein Jadvar, et al.
Hellenic Journal of Nuclear Medicine|August 14, 2009
Prostate cancer incidence, mortality, total and free prostate specific antigenAlphathanasios Bantis, Olga Vasiliou
Hellenic Journal of Nuclear Medicine|August 14, 2009
Comparison of the effect of positive and negative oral contrast agents on (18)F-FDG PET/CT scanXiao-Guang Sun, Gang Huang, Jian-Jun Liu, et al.
Hellenic Journal of Nuclear Medicine|August 14, 2009
A pilot study of changes in (18)F-FDG uptake, calcification and global metabolic activity of the aorta with agingGonca G Bural, Drew A Torigian, Elias Botvinick, et al.
Hellenic Journal of Nuclear Medicine|August 14, 2009
TSH receptor antibodies for confirming the diagnosis and prediction of remission duration, in newly diagnosed Graves' disease patientsAleksandar Aleksić, Zeljka Aleksić, Miodrag Stojanović
Hellenic Journal of Nuclear Medicine|August 14, 2009
Can response to palliative treatment with radiopharmaceuticals be further enhanced?Athanasios Zafeirakis
Pageof 113